News
$AMLX.US$ Reuters· 3 mins ago
Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for Amx0035 for the Treatment of Wolfram Syndrome
Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for Amx0035 for the Treatment of Wolfram Syndrome
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Abela : Ppl are not interested i guess
Trytosaveabit OP Abela : Could be another bad day in overall market? Most futures are red! Especially NASDAQ last I looked
Abela Trytosaveabit OP : What you![goat 🐐](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f410.png)
![v ✌️](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/270c-fe0f.png)
Abela Trytosaveabit OP : Any thoughts on$CNSP.US$ and $KAVL.US$
stockmarkettec : Just Looking![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
and thanks for the ideas & info ![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Trytosaveabit OP stockmarkettec : You’re welcome! GL
steven smith38 : that's all u. even ha e tour own category on watch list. it say try.